Article: PROTOGENE SPINS OUT NEW RESEARCH COMPANY AND SELLS DNA SYNTHESIS SERVICE TO LIFE TECHNOLOGIES

PALO ALTO, Calif., Feb. 15 /PRNewswire/ -- Protogene Laboratories, Inc. announced today that it sold its rapidly growing custom DNA synthesis service to its marketing partner, Life Technologies, Inc. (LTI) (Nasdaq: LTEK) of Gaithersburg, MD. As part of the transaction, Protogene split out a new research company to develop new applications of the company's DNA manipulation and parallel array synthesis technologies.

The parallel array synthesis technology was developed by Dr. Thomas Brennan and others at Stanford University's Human Genome Center. The development of the instrument at Stanford was supported by a Human Genome Program grant from the Department of Energy.

...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!